Camber Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,350,000
Closed -$12.2M 40
2024
Q2
$12.2M Sell
1,350,000
-1,400,000
-51% -$9.76M 0.34% 32
2024
Q1
$22.5M Buy
2,750,000
+1,750,000
+175% +$14.4M 0.55% 27
2023
Q4
$8.43M Sell
1,000,000
-1,000,000
-50% -$11.6M 0.21% 36
2023
Q3
$34.2M Buy
2,000,000
+450,000
+29% +$8.84M 1.13% 24
2023
Q2
$36M Buy
1,550,000
+300,000
+24% +$5.86M 1.17% 24
2023
Q1
$22.1M Buy
1,250,000
+250,000
+25% +$5.95M 0.68% 28
2022
Q4
$27.2M Buy
+1,000,000
New +$20.8M 0.93% 23

Other funds holding REPL

Camber Capital Management's REPL Position: Q3 2024 in Review

Camber Capital Management sold out of Replimune Group (REPL) in Q3 2024, closing a stake of 1,350,000 shares — an estimated $12.2M sold.

Camber Capital Management first reported a position in REPL in Q4 2022 and held it in 7 quarters. The position peaked at $36M in Q2 2023. 144 funds tracked by Wall St. Rank hold REPL as of Q3 2024.

  • Camber Capital Management reported no remaining Replimune Group position as of Q3 2024 after selling out during the quarter.
  • Camber Capital Management sold 1,350,000 Replimune Group shares in Q3 2024, an estimated $12.2M.
  • Camber Capital Management first reported a position in Replimune Group in Q4 2022 and held it in 7 quarters.
  • Camber Capital Management's Replimune Group position peaked at $36M in Q2 2023.
  • 144 funds tracked by Wall St. Rank held Replimune Group as of Q3 2024.

Based on Camber Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.